The Impact of Germline Genetic Variations in Hydroxysteroid (17-Beta) Dehydrogenases on Prostate Cancer Outcomes After Prostatectomy

详细信息	查看全文 | 推荐本文 |

• 作者：É ; tienne Audet-Walsh^a ; Judith Bellemare^a ; Louis Lacombe^b ; Yves Fradet^b ; Vincent Fradet^b ; Pierre Douville^b ; Chantal Guillemette^a ; ^{chantal.guillemette@crchul.ulaval.ca} ; É ; ric Lé ; vesque^a ; ^b ; ^{eric.levesque@crchuq.ulaval.ca}
• 关键词：Prostate cancer ; Germline polymorphisms ; Biochemical recurrence ; Prostate cancer progression ; 17尾-HSD genes ; HSD17B2 ; HSD17B3 ; HSD17B12
• 刊名：European Urology
• 出版年：2012
• 期刊代码：289_03022838
• 类别：med
• 出版时间：July, 2012
• 卷：62
• 期：1
• 页码：88-96
• 文件大小：488 K

摘要

Background

The relationship between polymorphisms in the hydroxysteroid (17-beta) dehydrogenase (HSD17B) family of genes, which are involved in steroid hormone biotransformation, and the risk of prostate cancer (PCa) progression remains unexplored.

Objective

Determine whether inherited variations in HSD17B genes are associated with PCa progression.

Design, setting, and participants

We studied two independent Caucasian cohorts composed of 526 men with organ-confined PCa and 213 men with advanced disease who had a median follow-up of 7.4 yr and 7.8 yr after surgery, respectively.

Measurements

Patients with localised PCa were genotyped for 88 haplotype-tagging single nucleotide polymorphisms in HSD17B type 1 (HSD17B1), type 2 (HSD17B2), type 3 (HSD17B3), type 4 (HSD17B4), type 5 (HSD17B5), and type 12 (HSD17B12), and their prognostic significance on disease progression was assessed using Kaplan-Meier survival curves and Cox regression models. Positive findings were then investigated in advanced disease.

Results and limitations

After adjusting for known risk factors, 12 SNPs distributed across HSD17B2, HSD17B3, and HSD17B12 were significantly associated with risk of biochemical recurrence (BCR) in localised PCa (for variants in HSD17B2: hazard ratio [HR]: 1.92-2.93; p = 0.025-0.004). In addition, four variants of HSD17B2 (rs1364287, rs2955162, rs1119933, rs9934209) were significantly associated with progression-free survival (HR: 2.96-4.69; p = 0.004-0.00005) and overall survival in advanced disease (HR: 3.98-8.14; p = 0.003-0.00002). Four variants of HSD17B3 and HSD17B12 were associated with a reduced risk of BCR (HR: 0.51-0.65; p = 0.020-0.036) but not with progression in advanced disease. These results were generated mainly in Caucasians and should be studied in other ethnic groups.

Conclusions

This study suggests a prominent role for common genetic variants in the HSD17B2 pathway in PCa progression.